Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GS-5806 versus placebo for upper respiratory tract RSV infection in hematopoietic cell transplant recipients
RBR-4hm9bfPhase 2Not yet recruiting
- Sponsor
- Fundação Doutor Amaral Carvalho
- Start
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of presatovir in respiratory syncytial virus disease (RSV), upper respiratory infection (URI), sponsored by Fundação Doutor Amaral Carvalho. Planned start Jul 2015; status: not yet recruiting.
02
Drugs
presatovir
03
Conditions
respiratory syncytial virus disease (RSV)upper respiratory infection (URI)
Beyond the preview
Go deeper on RBR-4hm9bf.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-4hm9bf.